Dhara Waghela Sheth

Dhara Waghela Sheth is an associate in the Corporate Practice Group in the firm's Century City office and is a member of the firm’s Healthcare and Life Sciences teams.

Areas of Practice  

Dhara focuses her practice on joint ventures, mergers, acquisitions, general corporate matters, and compliance matters primarily in the healthcare and life science industries. She represents a variety of clients including medical groups, private equity firms, and medical device companies. Dhara’s experience includes corporate formations, drafting transactional documents, efficiently managing due diligence investigations, and ensuring compliance with federal and state regulations.

Honors

2022 Hot List, Lawyers of Color, 2022

Articles

Healthcare Law Blog Posts

• "Putting the Brakes on Healthcare M&A and Provider/Payor Contracting: AB 2080 Poised to Dramatically Impact Healthcare Transactions in California," July 7, 2022
• "HIPAA and COVID-19 Vaccination Status: The Office of Civil Rights Issues Workplace Guidance," October 13, 2021
• "Executive Order on Promoting Competition in the American Economy: The Biden Administration Considers Drug Pricing Strategies While Keeping the “Most Favored Nations” Drug Reimbursement Program on the Sidelines," August 20, 2021
• "The American Rescue Plan Act of 2021: A New Lease on Life for the Affordable Care Act?" March 26, 2021
• "Medicare Part B Most Favored Nation Drug Pricing Model: New Rules, New Lawsuits, New Tweets," December 21, 2020

• "ERISA: The Erosion of State Health Regulation Rights," November 24, 2020

• "The Death of RBG…and the ACA?," September 25, 2020

• "The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry," September 17, 2020

• "President Trump’s Executive Order Mandating the Purchase of U.S. Drugs Evokes Criticism," August 18, 2020

• "The California Department of Managed Health Care Extends the Phase-In Period for the General Licensure Regulation," April 29, 2020
• "Supreme Court Issues Long Awaited Ruling on Affordable Care Act Risk Corridors Program," April 27, 2020

• "Telehealth and Online Prescribing: COVID-19 Triggers Changes to the Prescriber/Patient/Pharmacist Relationship," April 21, 2020

• "California Department of Managed Health Care Releases Additional Guidance on Telehealth Services," April 15, 2020
• "CMS Issues Temporary Waivers in Broad Coronavirus Response," April 2, 2020
• "Coronavirus Aid, Relief, And Economic Security Act Of 2020: Telehealth Front and Center," March 30, 2020

• "California Health Plans Take Note: California Department of Managed Health Care issues All Plan Letter on Social Distancing and COVID-19," March 18, 2020

• "The California Consumer Privacy Act of 2018: Why the Healthcare Sector Needs to Pay Attention (and Not Just in California)," November 21, 2019
• "CMS’s Mandatory Radiation Oncology Payment Model: Negative Reactions in the Radiation Oncology Treatment Community," October 28, 2019  
• "No Longer in Suspense: CMS Issues Final Rule Announcing that Risk Adjustment Program Transfers for 2017 will be Distributed in September," July 27, 2018
• "In a Unanimous Vote, the Opioid Crisis Response Act of 2018 Makes it Onto the Legislative Calendar," June 6, 2018